XML 85 R27.htm IDEA: XBRL DOCUMENT

2023 GXII TRANSACTION (Tables)

12 Months Ended

Jun. 30, 2024

Business Combination and Asset Acquisition [Abstract]

The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023:

After the distribution of funds to GXII redeeming shareholders and prior to paying transaction costs incurred by GXII, $15,676 became available to the Company. The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023:

			Amount
Gross cash proceeds, net of transaction costs incurred by GXII		$	2,168
Less:
Cash costs associated with the 2023 Transactions:
Net liabilities assumed			392
Yorkville Equity Facility Financing Agreement – cash costs			1,996
Transaction costs expensed			6,715
Non-cash costs associated with the 2023 Transactions:
Private Warrants assumed at fair value			2,987
Earnout Shares assumed at fair value			13,195
Yorkville Equity Facility Financing Agreement – shares issued			650
Total transaction related losses incurred		$	23,767

The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows

The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows:

		Common Shares				Percentage
Legacy NioCorp Shareholders			28,246,621				93.90	%
Former GXII Class A Shareholders⁽¹⁾			1,753,821				5.83	%
Other⁽²⁾			81,213				0.27	%
Total Common Shares Outstanding Upon Completion of 2023 Transactions			30,081,655				100	%

	(1)	Includes 83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory services.
	(2)	Represents Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.